Steps forward for cancer precision medicine.

Salgado R1,2,3, Moore H4, Martens JWM5, Lively T4, Malik S4, McDermott U6, Michiels S7, Moscow JA4, Tejpar S8, McKee T4, Lacombe D9; IBCD-Faculty.

Author information

Abstract

The availability of targeted anticancer drugs and the relative affordability of genomic analyses has led to a growing expectation among patients with cancer that they can receive personalized treatment based on the genomic signature of their tumour. Here, we discuss some of the challenges and steps needed to bring such approaches into routine practice.